These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
cytotox of Ozi and POzi_final for ChemRxiv.pdf (1.94 MB)
Cytotoxicity of 2-oxazines and poly(2-oxazine)s in mouse fibroblast
Preprints are manuscripts made publicly available before they have been submitted for formal peer review and publication. They might contain new research findings or data. Preprints can be a draft or final version of an author's research but must not have been accepted for publication at the time of submission.
submitted on 17.01.2018 and posted on 17.01.2018by Zuzana Kroneková, Thomas Lorson, Juraj Kronek, Robert Luxenhofer
Poly(2-oxazoline)s are a polymer family that has received much attention in the last decade as biomaterials. In contrast, poly(2-oxazine)s, which can be viewed as their higher backbone homologue, have received much less attention. A first step towards the assessment as potential biomaterials is the evaluation of the cytotoxicity of the polymers. Therefore, a small selection of water soluble poly(2-oxazine)s are evaluated with respect to their cytotoxicity against 3T3 mouse fibroblasts. The polymers were tested at concentrations of up to 100 g/L for 24h. In addition, we studied the cytotoxicity of the monomers, namely 2-methyl-2-oxazine, 2-ethyl-2-oxazine and 2-propyl-2-oxazine in the same cell line. We found that neither monomers nor polymers exhibit a pronounced cytotoxicity. None of the monomers lead to any discernable effect on the cell viability in concentrations of up to 1 g/L with IC50 values ranging from 4 g/L to 20 g/L. Not surprisingly, the polymers poly(2-methyl-2-oxazine) and poly(2-ethyl-2-oxazine) exhibit even lower cytotoxicity with IC50 values ranging from 20 to 70 g/L. These preliminary but positive evaluation of the cytotoxicity of poly(2-methyl-2-oxazine) and poly(2-ethyl-2-oxazine) warrants further investigations on their use as biomaterials.